Company intelligence / Profile preview

WAVI Holding

Denver, Colorado, United States

Ownership: Private
Development stage: Other

Overview

WAVi commercially distributes the WAVi Desktop system, which collects EEG, event-related potentials, and heart rate variability data to generate reports that aid in the assessment of various neurological and cognitive conditions; the FDA has determined it is an unapproved medical device and issued an October 2023 warning letter citing lack of premarket approval and quality system violations.[10][8]

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Beyond the preview

Go deeper on WAVI Holding.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WAVI Holding.

Explore the full profile